- Home
- BCYC vs ASIX Comparison
BCYC vs ASIX Comparison
Compare BCYC & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCYC | ASIX |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.6M | 466.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCYC | ASIX |
|---|---|---|
| Price | $6.75 | $16.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | $18.73 | ★ $25.50 |
| AVG Volume (30 Days) | 240.5K | ★ 343.2K |
| Earning Date | 02-24-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 3.88% |
| EPS Growth | N/A | ★ 35.47 |
| EPS | N/A | ★ 1.92 |
| Revenue | $28,339,000.00 | ★ $1,491,348,000.00 |
| Revenue This Year | N/A | $1.02 |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | $8.60 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.03 | $14.10 |
| 52 Week High | $13.63 | $32.58 |
Technical Indicators
Market Signals| Indicator | BCYC | ASIX |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 41.27 |
| Support Level | $6.85 | $16.10 |
| Resistance Level | $7.34 | $17.38 |
| Average True Range (ATR) | 0.32 | 0.64 |
| MACD | 0.05 | -0.19 |
| Stochastic Oscillator | 40.21 | 5.67 |
Price Performance
Historical ComparisonAbout BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.